176 related articles for article (PubMed ID: 22556374)
1. HIV infection and atherosclerosis: evaluating the drivers of inflammation.
Maniar A; Ellis C; Asmuth D; Pollard R; Rutledge J
Eur J Prev Cardiol; 2013 Oct; 20(5):720-8. PubMed ID: 22556374
[TBL] [Abstract][Full Text] [Related]
2. Targeting Inflammation to Reduce Atherosclerotic Cardiovascular Risk in People With HIV Infection.
Titanji B; Gavegnano C; Hsue P; Schinazi R; Marconi VC
J Am Heart Assoc; 2020 Feb; 9(3):e014873. PubMed ID: 31973607
[No Abstract] [Full Text] [Related]
3. Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virus.
Beltrán LM; Rubio-Navarro A; Amaro-Villalobos JM; Egido J; García-Puig J; Moreno JA
Vasc Health Risk Manag; 2015; 11():35-48. PubMed ID: 25609975
[TBL] [Abstract][Full Text] [Related]
4. Atherosclerotic Cardiovascular Disease and Anti-Retroviral Therapy.
Kaplan-Lewis E; Aberg JA; Lee M
Curr HIV/AIDS Rep; 2016 Oct; 13(5):297-308. PubMed ID: 27562769
[TBL] [Abstract][Full Text] [Related]
5. HIV, atherosclerosis and inflammation: implications for treatment.
Chan W; Sviridov D; Dart AM
J HIV Ther; 2009 Nov; 14(3):61-8. PubMed ID: 20218241
[No Abstract] [Full Text] [Related]
6. Partners in Crime: The Role of CMV in Immune Dysregulation and Clinical Outcome During HIV Infection.
Freeman ML; Lederman MM; Gianella S
Curr HIV/AIDS Rep; 2016 Feb; 13(1):10-9. PubMed ID: 26810437
[TBL] [Abstract][Full Text] [Related]
7. HIV and inflammation: mechanisms and consequences.
Hunt PW
Curr HIV/AIDS Rep; 2012 Jun; 9(2):139-47. PubMed ID: 22528766
[TBL] [Abstract][Full Text] [Related]
8. HIV, inflammation, and calcium in atherosclerosis.
Shrestha S; Irvin MR; Grunfeld C; Arnett DK
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):244-50. PubMed ID: 24265418
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular implications from untreated human immunodeficiency virus infection.
Baker JV; Lundgren JD
Eur Heart J; 2011 Apr; 32(8):945-51. PubMed ID: 21228007
[TBL] [Abstract][Full Text] [Related]
10. Cytomegalovirus as an Uninvited Guest in the Response to Vaccines in People Living with HIV.
Royston L; Isnard S; Lin J; Routy JP
Viruses; 2021 Jun; 13(7):. PubMed ID: 34209711
[TBL] [Abstract][Full Text] [Related]
11. Systemic and cell-specific mechanisms of vasculopathy induced by human immunodeficiency virus and highly active antiretroviral therapy.
Haser GC; Sumpio B
J Vasc Surg; 2017 Mar; 65(3):849-859. PubMed ID: 26994951
[TBL] [Abstract][Full Text] [Related]
12. Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis.
Rosenfeld ME; Campbell LA
Thromb Haemost; 2011 Nov; 106(5):858-67. PubMed ID: 22012133
[TBL] [Abstract][Full Text] [Related]
13. How Monocytes Contribute to Increased Risk of Atherosclerosis in Virologically-Suppressed HIV-Positive Individuals Receiving Combination Antiretroviral Therapy.
Jaworowski A; Hearps AC; Angelovich TA; Hoy JF
Front Immunol; 2019; 10():1378. PubMed ID: 31275317
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of Subclinical Atherosclerosis and Risk of Atherosclerotic Cardiovascular Disease in Older Adults Living with HIV.
Aurpibul L; Srithanaviboonchai K; Rerkasem K; Tangmunkongvorakul A; Sitthi W; Musumari PM
AIDS Res Hum Retroviruses; 2019; 35(11-12):1136-1142. PubMed ID: 31382762
[TBL] [Abstract][Full Text] [Related]
15. Impact of HIV infection on aging and immune status.
Blanco JR; Negredo E; Bernal E; Blanco J
Expert Rev Anti Infect Ther; 2021 Jun; 19(6):719-731. PubMed ID: 33167724
[No Abstract] [Full Text] [Related]
16. Cytomegalovirus Seropositivity Is Associated With Increased Microbial Translocation in People Living With Human Immunodeficiency Virus and Uninfected Controls.
Ramendra R; Isnard S; Lin J; Fombuena B; Ouyang J; Mehraj V; Zhang Y; Finkelman M; Costiniuk C; Lebouché B; Chartrand-Lefebvre C; Durand M; Tremblay C; Ancuta P; Boivin G; Routy JP
Clin Infect Dis; 2020 Sep; 71(6):1438-1446. PubMed ID: 31608409
[TBL] [Abstract][Full Text] [Related]
17. Mechanisms and primary prevention of atherosclerotic cardiovascular disease among people living with HIV.
Durstenfeld MS; Hsue PY
Curr Opin HIV AIDS; 2021 May; 16(3):177-185. PubMed ID: 33843806
[TBL] [Abstract][Full Text] [Related]
18. HIV and hepatitis C coinfection: pathogenesis and microbial translocation.
Page EE; Nelson M; Kelleher P
Curr Opin HIV AIDS; 2011 Nov; 6(6):472-7. PubMed ID: 21918438
[TBL] [Abstract][Full Text] [Related]
19. Inflammation in HIV and Its Impact on Atherosclerotic Cardiovascular Disease.
Obare LM; Temu T; Mallal SA; Wanjalla CN
Circ Res; 2024 May; 134(11):1515-1545. PubMed ID: 38781301
[TBL] [Abstract][Full Text] [Related]
20. HIV and cardiovascular disease: the role of inflammation.
Dirajlal-Fargo S; Funderburg N
Curr Opin HIV AIDS; 2022 Sep; 17(5):286-292. PubMed ID: 35938462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
